510(k) device
Serenity
Sanuthera, Inc. · Masker, Tinnitus (KLW, Class II) · First FDA decision Jul 27, 2015, newest Jul 27, 2015Tinnitus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
6
Naming "Serenity"
MAUDE reports
31
Brand "Serenity", since 2015
PubMed studies
380
Mentioning "Serenity"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Serenity
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Serenity510(k)
K150014 · Decided Jul 27, 2015 · 203 days after receipt
Device type: Masker, Tinnitus (KLW) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Serenity", any status and sponsor, newest update first.
KK Women's and Children's HospitalGovernment (non-federal)
NCT06929208 · 120 participants (planned) · Start Aug 19, 2025 · Primary completion Dec 2027
Device: Electrocardiogram (ECG) monitor · For: Heart Rate Variability; Anxiety; Depression
Sites: Singapore, Singapore · 3 sites in all
- Clinical Trial on the Visual Function of Enhanced Monofocal and EDoF Intraocular LensesNot yet recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauAcademic, hospital or other
NCT07715071 · 90 participants (planned) · Start Sep 21, 2026 · Primary completion Mar 31, 2027
Device: Intraocular lens · For: Cataract
CARESP: Cellule d'animation régionale en soins palliatifsAcademic, hospital or other
NCT06786962 · 43 participants · Start Nov 4, 2024 · Primary completion Feb 2, 2025
Device: Virtual reality Hypnosis · For: Hypnosis; Virtual Reality Therapy; Stress and 4 more
Sites: Rennes, France
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Serenity", and for the whole product code for context.
This brand
31 reports: 23 malfunction, 8 injury, 0 death
Whole product code KLW
4 reports: 1 malfunction, 3 injury, 0 death
Newest reports for this brand
- Advance Serenity 18Malfunction
3005994106-2026-00007 · Received Sep 16, 2026 · Event dated Aug 12, 2026
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT)
Device problem as coded: Material Separation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Advance Serenity 18Malfunction
3005994106-2026-00001 · Received Sep 16, 2026 · Event dated Dec 10, 2025
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT)
Device problem as coded: Failure to Deflate
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Advance Serenity 18Malfunction
3005994106-2026-00006 · Received Aug 19, 2026 · Event dated Jul 28, 2026
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT)
Device problem as coded: Difficult to Remove
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Serenity"[tiab]. The summary above synthesizes these.
- Nurse Serenity Lounges.
Katz J · Am J Nurs · 2022Letter
- Serenity, Courage, and Wisdom.
Fuller S · Ann Thorac Surg · 2024Editorial, Comment
- [Not Available].
Chamayou S · Soins · 2023English Abstract, Review
- Nurse Serenity Lounges.
Am J Nurs · 2022Letter
- Nurse Serenity Lounges.
Am J Nurs · 2022Letter
- Love and Medicine.
Kanne T · JAMA · 2024
- When Joy Met Serenity.
Catlett L · Am J Nurs · 2026
- The River of Aural Serenity: selected papers from the 2017 Annual Conference of the National Hearing Conservation Association.
Tufts JB, Giguère C · Int J Audiol · 2018Editorial, Introductory Journal Article
- Achievement of serenity.
Leake CD · Geriatrics · 1966Biography, Historical Article
- Neurobiology: serotonin sustains serenity.
Snyder SH · Nature · 2002Comment, News
- Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.
Laufs U, Banach M, Mancini GBJ, et al. · J Am Heart Assoc · 2019Clinical Trial, Phase III, Multicenter Study
- [Serenity and objectivity in the face of severe childhood hepatitis: the diagnostic challenge].
Moreno-Hernández MP, Cabrera-Gaytán DA, Hernández-Bautista PF · Rev Med Inst Mex Seguro Soc · 2022Editorial
Other devices of this type
Also filed under product code KLW.
- Tinnitus Sound Generator ModuleGN Hearing A/S · 510(k) 2020
- Tinnitus Sound Generator ModuleGn Resound A/S · 510(k) 2015
- Multiflex Tinnitus TechnologyStarkey Laboratories, Inc. · 510(k) 2020
- SoundCure Serenade Tinnitus Treatment SystemSoundcure, Inc. · 510(k) 2015
- Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation · 510(k) 2026
- Tinnitus TherapySivantos GmbH · 510(k) 2026
- Peace N Quiet (0.7.0)Pnq Health · 510(k) 2024
- Tinearity G1 (6103)Duearity AB · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.